Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1971 1
1978 1
1992 2
1993 4
1994 2
1995 1
1996 1
1997 2
1998 1
2001 3
2002 2
2003 1
2004 2
2007 1
2008 1
2009 3
2010 2
2011 1
2013 3
2014 13
2015 10
2016 2
2017 3
2018 1
2020 1
2021 2
2022 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Galectins in cancer: carcinogenesis, diagnosis and therapy.
Ebrahim AH, Alalawi Z, Mirandola L, Rakhshanda R, Dahlbeck S, Nguyen D, Jenkins M, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M. Ebrahim AH, et al. Among authors: figueroa ja. Ann Transl Med. 2014 Sep;2(9):88. doi: 10.3978/j.issn.2305-5839.2014.09.12. Ann Transl Med. 2014. PMID: 25405163 Free PMC article. Review.
Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.
Pena C, Mirandola L, Figueroa JA, Hosiriluck N, Suvorava N, Trotter K, Reidy A, Rakhshanda R, Payne D, Jenkins M, Grizzi F, Littlefield L, Chiriva-Internati M, Cobos E. Pena C, et al. Among authors: figueroa ja. Ann Transl Med. 2014 Sep;2(9):87. doi: 10.3978/j.issn.2305-5839.2014.09.14. Ann Transl Med. 2014. PMID: 25405162 Free PMC article. Review.
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
Mirandola L, Nguyen DD, Rahman RL, Grizzi F, Yuefei Y, Figueroa JA, Jenkins MR, Cobos E, Chiriva-Internati M. Mirandola L, et al. Among authors: figueroa ja. Int Rev Immunol. 2014 Oct;33(5):417-27. doi: 10.3109/08830185.2014.911855. Epub 2014 May 6. Int Rev Immunol. 2014. PMID: 24801755 Review.
Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W. Lu C, et al. Among authors: figueroa ja. Curr Cancer Drug Targets. 2015;15(7):575-92. doi: 10.2174/156800961507150828223554. Curr Cancer Drug Targets. 2015. PMID: 26324128 Review.
Sperm protein 17 is an oncofetal antigen: a lesson from a murine model.
Arnaboldi F, Menon A, Menegola E, Di Renzo F, Mirandola L, Grizzi F, Figueroa JA, Cobos E, Jenkins M, Barajon I, Chiriva-Internati M. Arnaboldi F, et al. Among authors: figueroa ja. Int Rev Immunol. 2014 Oct;33(5):367-74. doi: 10.3109/08830185.2014.911856. Epub 2014 May 8. Int Rev Immunol. 2014. PMID: 24811209 Review.
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M. Figueroa JA, et al. Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Int Rev Immunol. 2015. PMID: 25901860 Review.
Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.
Colombo M, Mirandola L, Reidy A, Suvorava N, Konala V, Chiaramonte R, Grizzi F, Rahman RL, Jenkins MR, Nugyen DD, Dalhbeck S, Cobos E, Figueroa JA, Chiriva-Internati M. Colombo M, et al. Among authors: figueroa ja. Int Rev Immunol. 2015 Mar;34(2):188-99. doi: 10.3109/08830185.2015.1027629. Int Rev Immunol. 2015. PMID: 25901861 Free article. Review.
70 results